Optimizing heparin compounds: a working construct for future antithrombotic drug development.
Becker
Richard C
RC
Cardiovascular Thrombosis Center, Duke University Medical Center, Duke Clinical Research Institute, Durham, NC 27715, USA. becke021@mc.duke.edu
D000818:Animals; D015195:Drug Design; D005343:Fibrinolytic Agents / Q000737:chemistry / Q000627:therapeutic use*; D006493:Heparin / Q000737:chemistry / Q000627:therapeutic use*; D006801:Humans
D005343:Fibrinolytic Agents; D006493:Heparin